Financial Performance - Net sales decreased by $105 million (or 6%) to $1.5 billion for Q2 2024 compared to $1.6 billion in Q2 2023, primarily due to a 6% decrease in price [259]. - For the six months ended June 30, 2024, net sales decreased by $292 million (or 9%) to $2.9 billion from $3.2 billion in the same period in 2023, driven by a 5% decrease in price and a 3% decrease in volume [260]. - Titanium Technologies segment net sales decreased by $34 million (or 5%) to $673 million for the three months ended June 30, 2024, primarily due to a 7% decrease in price [277]. - Thermal & Specialized Solutions segment net sales decreased by $10 million (or 2%) to $513 million for the three months ended June 30, 2024, primarily due to a 4% decrease in price [283]. - Advanced Performance Materials segment net sales decreased by $48 million (or 12%) to $339 million for the three months ended June 30, 2024, primarily due to a 7% decrease in price and a 4% decrease in volume [287][288]. - Performance Solutions portfolio's net sales were $133 million for Q2 2024, down from $140 million in Q2 2023, while Advanced Materials portfolio's net sales decreased from $247 million to $206 million in the same period [290]. - Net sales for the six months ended June 30, 2024, were $1,982 million, with a gross profit of $298 million [326]. Expenses and Costs - Cost of goods sold (COGS) decreased by $1 million (or less than 1%) to $1.2 billion for Q2 2024, and by $107 million (or 4%) to $2.3 billion for the six months ended June 30, 2024 [261]. - Selling, general, and administrative (SG&A) expenses decreased by $640 million (or 82%) to $139 million for Q2 2024, primarily due to litigation-related charges of $592 million recorded in Q2 2023 [262]. - Research and development (R&D) expenses decreased by $2 million (or 7%) to $26 million for Q2 2024, driven by transformation initiatives within the Titanium Technologies business [263]. - Interest expense, net increased by $18 million (or 38%) to $66 million for Q2 2024, primarily due to higher interest rates on variable rate debt and increased debt principal [266]. - Corporate expenses and unallocated items totaled $207 million for the six months ended June 30, 2024, down from $820 million in the same period of 2023 [296]. Cash Flow and Liquidity - Total unrestricted cash and cash equivalents were $604 million as of June 30, 2024, with $432 million held by foreign subsidiaries [298]. - The availability under the Revolving Credit Facility was $852 million as of June 30, 2024, net of $48 million in outstanding letters of credit [298]. - The company incurred a net $895 million usage of cash in operating activities for the six months ended June 30, 2024, compared to a net $57 million usage in the same period of 2023 [301]. - The company accelerated the collection of approximately $128 million of accounts receivable in the first half of 2024, compared to $205 million in the same period of 2023 [303]. - The company received approximately $259 million of net cash in the U.S. through intercompany loans and dividends during the six months ended June 30, 2024 [304]. - Cash used for operating activities increased to $910 million in the first half of 2024, primarily due to the release of $592 million from the qualified settlement fund [313]. - Cash used for investing activities was $171 million in the first half of 2024, mainly for property, plant, and equipment purchases totaling $175 million [314]. Environmental and Sustainability Initiatives - The company aims to achieve ambitious Corporate Responsibility Commitment goals by 2030, focusing on sustainability and long-term earnings growth [254]. - The company is committed to integrating sustainability across its operations and investing in R&D to develop safer and more efficient products [254]. - Chemours aims for a 60% reduction in Scope 1 and Scope 2 absolute GHG emissions by 2030, aligning with its Environmental Leadership goals [359]. - The company has set a new Scope 3 target to reduce emissions by 25% per ton of product by 2030, approved by the Science Based Targets initiative in May 2024 [360]. - Chemours has committed to a 99% or more reduction of air and water process emissions of fluorinated organic chemicals by 2030 [359]. - The company is continuously evaluating market trends and opportunities for low-carbon and energy-efficient products in response to evolving climate-related legislation [361]. - The Chemours Company aims to achieve a goal of avoiding 325 million tons of carbon dioxide equivalent emissions globally by the end of 2025 through its low GWP Opteon™ products [362]. Legal and Regulatory Matters - The company accrued litigation costs of $175 million as of June 30, 2024, which includes a $55 million settlement with the State of Ohio and a $13 million supplemental payment to the State of Delaware [307]. - The Chemours Company anticipates significant cash payments for known contractual obligations, including $580 million for environmental remediation liabilities as of June 30, 2024, with $127 million classified as current [306]. - The company has established an escrow account for potential future legacy PFAS liabilities, with a next escrow payment of $50 million expected by September 30, 2025, and annual payments through 2028 [307]. - The estimated earliest entry into force of PFAS restrictions in the EU is 2025, pending completion of the regulatory process [370]. - Chemours has appealed the EU's decision to list HFPO Dimer Acid as a Substance of Very High Concern, which may lead to future regulatory restrictions [368]. Assets and Liabilities - The Chemours Company reported a decrease in total current assets to $2.937 billion as of June 30, 2024, down from $3.835 billion at December 31, 2023 [317]. - Accounts and notes receivable increased by $286 million (or 47%) to $896 million at June 30, 2024, driven by higher sales in Q2 2024 [318]. - Current liabilities decreased to $1.557 billion at June 30, 2024, from $2.486 billion at December 31, 2023, primarily due to a reduction in accounts payable [321]. - Long-term liabilities as of June 30, 2024, were $4,867 million, slightly down from $4,931 million as of December 31, 2023 [327]. - Total environmental remediation liabilities decreased from $590 million as of December 31, 2023, to $580 million as of June 30, 2024 [341]. - The five most significant environmental remediation sites account for 81% of total accrued liabilities, with expected spending of $171 million over the next three years [341]. Foreign Currency and Interest Rate Management - As of June 30, 2024, Chemours had 11 foreign currency forward contracts with a gross notional value of $208 million, resulting in net gains of $3 million for the quarter [374]. - The company entered into interest rate swaps with a notional value of $300 million to mitigate cash payment volatility, recognizing pre-tax gains of $1 million for the quarter ended June 30, 2024 [377]. - The company designated euro-denominated debt as a hedge of its net investment in international subsidiaries, recognizing pre-tax gains of $13 million and $27 million for the three and six months ended June 30, 2024, respectively [376].

EXHIBIT 99.1 The Chemours Company Reports Second Quarter 2024 Results Wilmington, Del., August 1, 2024 – The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global leader in delivering innovative performance chemistry through Titanium Technologies ("TT"), Thermal & Specialized Solutions ("TSS"), and Advanced Performance Materials ("APM"), today announced its financial results for the second quarter 2024. Key Second Quarter 2024 Results & Highlights • Net Sales of $1.5 billion, down 6% year-over ...

Key Takeaways UBS upgraded chemicals company Chemours, arguing that the market has been too negative on the stock, which it believes can outperform. The analysts raised their rating to "buy," and increased the price target by $2. UBS said Chemours will benefit from higher profits from colorant titanium dioxide (TiO2) and demand for its next-generation refrigerants. The Chemours Co. (CC) shares gained in intraday trading Tuesday following an upgrade from UBS analysts, who said investors have been too negativ ...

Chemours (CC) shares ended the last trading session 5.5% higher at $25.56. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 16.8% loss over the past four weeks. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. Chemours is a mem ...

About This Article ■ Dear readers/followers, Sometimes the stars line up, and you manage to "catch" a company at exactly the right place. Such was the ease with Chemours during my last pices. That is why despite the recent downturn, my position in the company, and especially the one I bought at the time, is up over 22% compared to a market only up 5%. And this was back in February of this year. Seeking Alpha Chemours RoR (Seeking Alpha Chemours RoR) Chemours - An upside remains, even with the halted product ...

Carpenter Technology currently carries a Zacks Rank #1. CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 15.1%. The company's shares have soared 112.7%% in the past year. The Zacks Consensus Estimate for Ecolab's current-year earnings is pegged at $6.56 per share, indicating a year-over-year rise of 25.9%. ECL, a Zacks Rank #2 stock, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 1.3%. T ...

A month has gone by since the last earnings report for Chemours (CC) . Shares have lost about 2.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Chemours due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Chemours' Earnings Beat, Revenues Miss Estimates in Q1 Ch ...

LOS ANGELES, May 17, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Class Period: February 10, 2023 – February 28, 2024 Lead Plaintiff Deadline: May 20, 2024 If you are a shareholder who suffered a loss, click here to participate. The complaint filed alleges that, throughout the Class Period, Defendants failed to dis ...

NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Chemours and certain of its officers ...

Chemours Co (NYSE:CC) Q1 2024 Results Conference Call May 1, 2024 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President and Chief Executive Officer Matt Abbott - Chief Financial Officer Conference Call Participants Duffy Fischer - Goldman Sachs John McNulty - BMO Capital Markets Josh Spector - UBS Financial Hassan Ahmed - Alembic Global Advisors Mike Leithead - Barclays Turner Hinrichs - Morgan Stanley Operator Good morning. My name is Lovely, and I ...